CST6 and metastatic malignant neoplasm in the lymph nodes: Moreover, increased levels of cystatin M/E correlated with a high risk of lymph-node metastasis and a low disease-free survival rate, supporting that cystatin M/E could be used as an independent predictor of disease-free survival in TNBC.